Chen Hong-Chi, You Ren-In, Lin Fang-Mei, Lin Guan-Ling, Ho Tsung-Jung, Chen Hao-Ping
Department of Biomedical Sciences and Engineering, Tzu Chi University, Hualien, 970374, Taiwan.
Department of Laboratory Medicine and Biotechnology, Tzu Chi University, Hualien, 970374, Taiwan.
Bot Stud. 2024 Jun 6;65(1):14. doi: 10.1186/s40529-024-00422-2.
The clinical efficacy of Jinchuang Ointment, a traditional Chinese medicine (TCM), in treating chronic non-healing diabetic wounds has been demonstrated over the past decades. Both in vitro and in vivo angiogenic activities have been reported for its herbal ingredients, including dragon blood from the palm tree Daemonorops draco and catechu from Uncaria gambir Roxb. Additionally, crude extracts of dragon blood have exhibited hypoglycemic effects not only in animal studies but also in cell-based in vitro assays.
Our findings indicate that crude dragon blood extract promotes the differentiation of myoblasts into myotubes. Partially purified fractions of dragon blood crude extract significantly enhance the expression of muscle cell differentiation-related genes such as myoG, myoD, and myoHC. Our results also demonstrate that crude extracts of dragon blood can inhibit platelet-derived growth factor-induced PAI-1 expression in primary rat vascular smooth muscle cells, thereby favoring changes in hemostasis towards fibrinolysis. Consistent with previous reports, reduced expression of plasminogen activator inhibitor 1 (PAI-1) accelerates wound healing. However, further separation resulted in a significant loss of both activities, indicating the involvement of more than one compound in these processes. Stem cells play a crucial role in muscle injury repair. Neither dragon blood nor catechu alone stimulated the proliferation of human telomerase reverse transcriptase (hTERT)-immortalized and umbilical cord mesenchymal stem cells. Interestingly, the proliferation of both types of stem cells was observed when crude extracts of dragon blood and catechu were present together in the stem cell growth medium.
Dragon blood from D. draco offers multifaceted therapeutic benefits for treating chronic nonhealing diabetic wounds from various perspectives. Most drugs in Western medicine consist of small molecules with defined ingredients. However, this is not the case in TCM, as the activities of dragon blood reported in this study. Surprisingly, the activities documented here align with descriptions in ancient Chinese medical texts dating back to A.D. 1625.
在过去几十年中,中药金创膏治疗慢性难愈合糖尿病伤口的临床疗效已得到证实。其草药成分,包括麒麟竭(来源于棕榈科植物麒麟竭)和儿茶(来源于钩藤),在体外和体内均具有血管生成活性。此外,麒麟竭粗提物不仅在动物研究中表现出降血糖作用,在基于细胞的体外试验中也有此效果。
我们的研究结果表明,麒麟竭粗提物可促进成肌细胞分化为肌管。麒麟竭粗提物的部分纯化组分显著增强了肌肉细胞分化相关基因如肌细胞生成素(myoG)、肌分化抗原(myoD)和肌球蛋白重链(myoHC)的表达。我们的结果还表明,麒麟竭粗提物可抑制血小板衍生生长因子诱导的原代大鼠血管平滑肌细胞中纤溶酶原激活物抑制剂1(PAI - 1)的表达,从而有利于止血向纤维蛋白溶解转变。与先前报道一致,PAI - 1表达降低可加速伤口愈合。然而,进一步分离导致这两种活性显著丧失,表明这些过程涉及不止一种化合物。干细胞在肌肉损伤修复中起关键作用。单独的麒麟竭或儿茶均未刺激人端粒酶逆转录酶(hTERT)永生化的脐带间充质干细胞的增殖。有趣的是,当麒麟竭和儿茶的粗提物同时存在于干细胞生长培养基中时,观察到这两种类型干细胞的增殖。
麒麟竭从多个角度为治疗慢性难愈合糖尿病伤口提供了多方面的治疗益处。西药中的大多数药物由成分明确的小分子组成。然而,中药并非如此,如本研究中报道的麒麟竭的活性。令人惊讶的是,这里记录的活性与公元1625年的中国古代医学文献中的描述一致。